K. Brammer

发表

Peptidoglycan Transpeptidase Inhibition in Pseudomonas aeruginosa and Escherichia coli by Penicillins and Cephalosporins

S. Jevons, B. Moore, K. Brammer, 1979, Antimicrobial Agents and Chemotherapy.

Inhibition of Transpeptidase Activity in Escherichia coli by Thienamycin

S. Jevons, B. Moore, K. Brammer, 1979, Antimicrobial Agents and Chemotherapy.

Ticonazole, a New Imidazole-Antifungal Agent for the Treatment of Dermatomycoses

M. Tarbit, J. K. Faulkner, S. Jevons, 1983 .

Tioconazole, a new imidazole-antifungal agent for the treatment of dermatomycoses. Antifungal and pharmacologic properties.

M. Tarbit, J. K. Faulkner, S. Jevons, 1983, Dermatologica.

The treatment of experimental schistosomiasis with a combination of oxamniquine and praziquantel.

J. Shaw, K. Brammer, 1983, Transactions of the Royal Society of Tropical Medicine and Hygiene.

6 beta-Iodopenicillanic acid (UI-38,006), a beta-lactamase inhibitor that extends the antibacterial spectrum of beta-lactam compounds: initial bacteriological characterization

B. Moore, K. Brammer, 1981, Antimicrobial Agents and Chemotherapy.

Management of fungal infection in neutropenic patients with fluconazole.

K. Brammer, 1990, Haematology and blood transfusion.

Pharmacokinetics and tissue penetration of fluconazole in humans.

J. K. Faulkner, P. Farrow, K. Brammer, 1990, Reviews of infectious diseases.

Pharmacokinetics of fluconazole in pediatric patients

P. Coates, K. Brammer, 1994, European Journal of Clinical Microbiology and Infectious Diseases.

Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in mice

P. Troke, R. Andrews, M. Marriott, 1985, Antimicrobial Agents and Chemotherapy.

Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. Multicentre Study Group.

G. Mufti, G. Ehninger, J. Wade, 1993, The Journal of antimicrobial chemotherapy.

Antiviral Properties of 1-Phenoxymethyl-3,4-Dihydro and 1,2,3,4-Tetrahydroisoquinolines

M. Tute, K. Brammer, C. R. Mcdonald, 1968, Nature.

Molecular Weight of Urokinase

K. Brammer, R. Burges, J. D. Coombes, 1965, Nature.

Activity of UK-49,858, a bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytes

P. Troke, K Richardson, K W Brammer, 1985, Antimicrobial Agents and Chemotherapy.

Chemical modification of viral ribonucleic acid. II. Bromination and iodination.

K. Brammer, 1963, Biochimica et biophysica acta.

Antifungal Activity of Tioconazole (UK-20,349), a New Imidazole Derivative

M. Leeming, S. Jevons, D. Cox, 1979, Antimicrobial Agents and Chemotherapy.

Tioconazole, a new broad-spectrum antifungal agent: preclinical studies related to vaginal candidiasis.

M. Tarbit, A. Monro, J. K. Faulkner, 1983, Gynakologische Rundschau.

Antifungal Activity ofTioconazole (UK-20,349), aNewImidazole Derivative

S. Jevons, D. Cox, K. Brammer, 1979 .

A comparison of fluconazole and ketoconazole in the oral treatment of vaginal candidiasis; report of a double-blind multicentre trial.

S. Leodolter, K. Brammer, E. Kutzer, 1988, European journal of obstetrics, gynecology, and reproductive biology.

The disposition and metabolism of [14C]fluconazole in humans.

M. Tarbit, S. Jezequel, A. Coakley, 1991, Drug metabolism and disposition: the biological fate of chemicals.

A comparison of single‐dose oral fluconazole with 3‐day intra‐vaginal clotrimazole in the treatment of vaginal candidiasis. Report of an international multicentre trial

J. Cohen, T. Bergan, C. Marhic, 1989 .

The detection and characterization of an induced RNA polymerase in the chorioallantoic membranes of embryonated eggs infected with influenza A2 virus.

M. Page, K. Brammer, J. D. Coombes, 1969, Virology.

The inhibition of viral neuraminidase by 1-phenoxymethyl-3,4-dihydroisoquinolines. I. Steric effects.

M. Tute, R. Broadbent, K. Brammer, 1970, Journal of medicinal chemistry.

368. The nucleotide sequence in deoxyribonucleic acids. Part V. The alkaline degradation of apurinic acids

A. S. Jones, K. Brammer, C. Bayley, 1961 .

Synthesis and antibacterial activity of 1-N-(1,3-dihydroxy-2-propyl)kanamycin B (UK-31,214).

J. Wright, S. Jevons, R. M. Plews, 1979, The Journal of antibiotics.

In Vitro Studies with UK-18,892, a New Aminoglycoside Antibiotic

S. Jevons, H. Cheeseman, K. Brammer, 1978, Antimicrobial Agents and Chemotherapy.

UK-18,892: Resistance to Modification by Aminoglycoside-Inactivating Enzymes

S. Jevons, R. Andrews, H. Cheeseman, 1978, Antimicrobial Agents and Chemotherapy.

Study of the use of alkaline degradation of DNA derivative as a procedure for the determination of nucleotide distribution.

R. T. Walker, A. Mian, A. S. Jones, 1968, Biochimica et biophysica acta.

Penetration of sulbactam into the cerebrospinal fluid of patients with bacterial meningitis receiving ampicillin therapy.

J. Stahl, M. Micoud, J. Bru, 1986, Reviews of infectious diseases.

Biliary pharmacokinetics of sulbactam plus ampicillin in humans.

D. Morris, C. Robertson, C. Ubhi, 1986, Reviews of infectious diseases.

An electrophorectic method for the detection and estimation of microgramme quantities of neomycin serum protein solutions.

K. Brammer, L. J. Hemson, 1965, Journal of Chromatography A.

A comparison of single‐dose oral fluconazole with 3‐day intravaginal clotrimazole in the treatment of vaginal candidiasis

J. Cohen, T. Bergan, C. Marhic, 1989, British journal of obstetrics and gynaecology.